Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Aditxt, Inc. ( (ADTX) ) is now available.
On March 21, 2025, Aditxt, Inc. hosted a corporate update featuring its CEO, Amro Albanna, and Saundra Pelletier, CEO of Evofem Biosciences, Inc., which is a strategic acquisition target. The update focused on recent achievements and strategic milestones, particularly highlighting Evofem’s commitment to women’s health through innovative products like Phexxi, a non-hormonal birth control, and SOLOSEC for bacterial vaginosis and trichomoniasis. The discussion underscored the ongoing partnership between Aditxt and Evofem, emphasizing the potential impact on women’s health globally and the strategic growth opportunities for both companies.
More about Aditxt, Inc.
YTD Price Performance: -79.70%
Average Trading Volume: 3,082,990
Technical Sentiment Signal: Strong Buy
Current Market Cap: $9.93M
See more insights into ADTX stock on TipRanks’ Stock Analysis page.